8-KOther EventsExhibits & Filings

CME GROUP INC. 8-K Report, Corporate Update (Aug 8, 2008)

Filed August 8, 2008For Securities:CME

Summary

CME Group Inc. (CME) filed a Current Report on Form 8-K on August 7, 2008, primarily to disclose the mailing of a Proxy Supplement dated August 7, 2008. This supplement was sent to holders of CME Group Class A common stock, NYMEX Holdings common stock, and NYMEX Class A members. It amends and provides additional information related to the previously filed joint proxy statement/prospectus dated July 21, 2008. The filing indicates that the supplement is part of the ongoing process related to the acquisition of NYMEX Holdings by CME Group. Investors should note that this 8-K filing itself does not contain new financial results or operational updates. Its significance lies in providing further details and clarifications pertinent to the upcoming shareholder and member votes required for the completion of the NYMEX acquisition. The attached Exhibit 99.1, the Proxy Supplement, is the critical document for understanding any revised terms, risks, or procedural information related to this significant corporate event.

Key Highlights

  • 1CME Group mailed a Proxy Supplement dated August 7, 2008, to relevant stakeholders.
  • 2The supplement is an addition to the joint proxy statement/prospectus previously filed on July 21, 2008.
  • 3The mailing was directed to holders of CME Group Class A common stock, NYMEX Holdings common stock, and NYMEX Class A members.
  • 4This filing serves as a notification of updated information for those involved in the voting process for the proposed transaction.
  • 5The document is filed under Item 8.01 (Other Events) of the Form 8-K.
  • 6The Proxy Supplement is attached as Exhibit 99.1 to this 8-K filing.
  • 7The filing is related to the acquisition of NYMEX Holdings, Inc. by CME Group Inc.

Frequently Asked Questions

The main purpose of this 8-K filing is to report that CME Group Inc. mailed a supplement to its joint proxy statement/prospectus to shareholders and members. This supplement provides updated information relevant to the proposed acquisition of NYMEX Holdings.

No, this 8-K filing does not contain new financial statements or results of operations. It solely reports the mailing of a proxy supplement related to an ongoing corporate transaction.

The proxy supplement was mailed to holders of CME Group Class A common stock, NYMEX Holdings common stock, and NYMEX Class A members.

The details of the information are contained within the Proxy Supplement dated August 7, 2008, which is attached as Exhibit 99.1 to this Form 8-K filing. Investors should review this exhibit for further information regarding the transaction.